Research Topics
| A C HoSummaryCountry: USA Publications
| Collaborators
|
Detail Information
Publications
Macular holeA C Ho
University of Pennsylvania Scheie Eye Institute, Retina Service, Philadelphia 19104, USA
Surv Ophthalmol 42:393-416. 1998..Surgical management with or without pharmacosurgical adjuncts can improve vision in select cases. The most common surgical complication is progressive lens opacification in phakic patients...- Laser-induced drusen reduction improves visual function at 1 year. Choroidal Neovascularization Prevention Trial Research GroupA C Ho
Retina Service, Wills Eye Hospital, Philadelphia, PA 19107, USA
Ophthalmology 106:1367-73; discussion 1374. 1999..To describe the relationship of laser-induced drusen reduction to change in visual function at 1 year among patients enrolled in the Choroidal Neovascularization Prevention Trial (CNVPT)... - Laser treatment in eyes with drusenA C Ho
Wills Eye Hospital, Philadelphia, Pennsylvania, USA
Curr Opin Ophthalmol 10:204-8. 1999..A definitive study, the Complications of Age-Related Macular Degeneration Prevention Trial, aims to evaluate the effects of laser treatment in patients with bilateral drusen and will commence this year... - Light energy, cataract surgery, and progression of age-related macular degenerationBradley T Smith
Wills Eye Hospital, Philadelphia, PA 19107, USA
Curr Opin Ophthalmol 16:166-9. 2005..The natural lens serves as a barrier to some of the higher energy light rays. There is some concern that cataract surgery may be contributing to the increase in prevalence of age-related macular degeneration... - Laser burn intensity and the risk for choroidal neovascularization in the CNVPT Fellow Eye StudyR S Kaiser
Scheie Eye Institute, University of Pennsylvania, 51 N 39th St, Philadelphia, PA 19104, USA
Arch Ophthalmol 119:826-32. 2001..CONCLUSION: Higher-intensity prophylactic laser applications appear to be associated with a greater risk for development of CNV and with more extensive drusen reduction... - Photodynamic therapy updateM F Shuler
Wills Eye Hospital, Philadelphia, Pennsylvania, USA
Curr Opin Ophthalmol 12:202-6. 2001..The socio-economic impact of verteporfin approval has yet to be determined... - Ultraviolet and near-blue light effects on the eyeBradley T Smith
Wills Eye Hospital, 840 Walnut Street, Philadelphia, PA 19107, USA
Int Ophthalmol Clin 45:107-15. 2005 - Pegaptanib for choroidal neovascularization in treatment-naïve exudative age-related macular degenerationJustis P Ehlers
Retina Service, Wills Eye Institute, Philadelphia, Pennsylvania 19107, USA
Ophthalmic Surg Lasers Imaging 38:371-7. 2007..To evaluate the use of intravitreal pegaptanib in the treatment of choroidal neovascularization secondary to age-related macular degeneration (AMD) in treatment-naive patients... - Short-term outcomes of 25-gauge vitrectomy with silicone oil for repair of complicated retinal detachmentChirag P Shah
From Wills Eye Institute, Philadelphia, Pennsylvania
Retina 28:723-8. 2008..To investigate the short-term outcomes of 25-gauge pars plana vitrectomy (PPV) in 18 cases of complicated retinal detachment requiring silicone oil tamponade... - Streptococcus mitis endophthalmitis presenting as frosted branch angiitis after intravitreal pegaptanib sodium injectionEric Chen
Retina Service, Wills Eye Institute, 840 Walnut Street, Suite 1020, Philadelphia, PA 19107, USA
Ophthalmic Surg Lasers Imaging 40:192-4. 2009..Because S. mitis can cause an endophthalmitis that presents as frosted branch angiitis, it must be considered in the differential diagnosis of patients who present with frosted branch angiitis... - Postoperative complications associated with 25-gauge pars plana vitrectomyOmesh P I Gupta
Retina Service, Wills Eye at Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Ophthalmic Surg Lasers Imaging 38:270-5. 2007..To report postoperative complications in eyes undergoing 25-gauge pars plana vitrectomy (PPV)... - Perioperative and operative considerations in diabeticsDavid R Fintak
Department of Ophthalmology, Wills Eye Hospital, 840 Walnut Street, Philadelphia, PA 19107, USA
Ophthalmol Clin North Am 19:427-34. 2006..Although these patients provide unique challenges to cataract surgeon, early intervention and appropriate preoperative, intraoperative, and postoperative considerations can lend to good outcomes... - Evaluation of the potential acuity meter in predicting visual acuity after photodynamic therapy for choroidal neovascularizationBradley T Smith
Wills Eye Hospital, 840 Walnut Street, Philadelphia, PA 19107, USA
Ophthalmic Surg Lasers Imaging 37:6-11. 2006..CONCLUSION: The eyes that demonstrated better visual acuity with the potential acuity meter in this study seemed more likely to experience an improvement in visual acuity after photodynamic therapy... - Retinal detachment from inadvertent intraocular injection of botulinum toxin AMimi Liu
Retina Service, Wills Eye Hospital, Philadelphia, Pennsylvania 19107, USA
Am J Ophthalmol 137:201-2. 2004..After 2 more days, her vision returned to baseline. CONCLUSIONS: Botox did not appear toxic to human intraocular tissues. Close observation may be indicated in the event of an inadvertent intraocular Botox injection... - Ranibizumab for exudative age-related macular degeneration in eyes previously treated with alternative vascular endothelial growth factor inhibitorsJustis P Ehlers
Wills Eye Institute, Philadelphia, Pennsylvania, USA
Ophthalmic Surg Lasers Imaging 41:182-9. 2010..To evaluate ranibizumab for exudative age-related macular degeneration previously treated with pegaptanib, bevacizumab, or both... - Pars plana vitrectomy versus combined pars plana vitrectomy-scleral buckle for primary repair of pseudophakic retinal detachmentEric D Weichel
Department of Ophthalmology, Walter Reed Army Medical Center, Washington, DC 20307, USA
Ophthalmology 113:2033-40. 2006..To evaluate pars plana vitrectomy (PPV) versus a combined PPV and scleral buckle (PPV/SB) for repair of noncomplex, pseudophakic retinal detachment... - [Treatment of neovascular age-related macular degeneration with antiangiogenic drugs]Eduardo Buchele Rodrigues
Departamento de Retina, Servico de Oftalmologia, Hospital Regional Sao Jose, Instituto de Olhos Florianópolis Centro Oftalmológico Florianópolis SC Brasil
Arq Bras Oftalmol 69:756-65. 2006..This paper presents the rationale and principles of the pharmacologic antiangiogenic therapy for CNV in ARMD... - Changing trends in the microbiologic aspects of postcataract endophthalmitisFranco M Recchia
Division of Vitreoretinal Diseases and Surgery, Vanderbilt Eye Institute, Nashville, Tenn 37232, USA
Arch Ophthalmol 123:341-6. 2005..To analyze the microbiologic spectrum and in vitro susceptibility profiles over the last 11 years of organisms isolated from the vitreous of patients with endophthalmitis following cataract surgery... - Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of OphthalmologyMichael S Ip
American Academy of Ophthalmology, Box 7424, San Francisco, CA 94120, USA
Ophthalmology 115:1837-46. 2008..To examine the evidence about the safety and efficacy of anti-vascular endothelial growth factor (VEGF) pharmacotherapies for the treatment of neovascular age-related macular degeneration (AMD)... - Risk factors for choroidal neovascularization and vision loss in the fellow eye study of CNVPTJonathan L Prenner
Associated Retinal Consultants, Royal Oak, Michigan, USA
Retina 23:307-14. 2003..Reticular pseudodrusen were present in only three eyes. CONCLUSIONS: Reticular pseudodrusen were rare. Late drusen fluorescence may protect against the development of CNV...